Skip to main content
. 2011 Sep 13;26(3):340–347. doi: 10.3904/kjim.2011.26.3.340

Table 2.

Meta-analysis of randomized controlled trials of monthly oral 150 mg ibandronate

graphic file with name kjim-26-340-i002.jpg

RR, relative risk; CI, confidence interval; AE, adverse effect; GI, gastrointestinal; BALTO, the Bonviva alendronate trial in osteoporosis; BMD, bone mineral density.

aWeighted mean difference.